We are live on ! Find out more
CASI

CASI Pharmaceuticals
CASI

Delisted

CASI was delisted on the 25th of February, 2026.

Back to rankings

6 hedge funds and large institutions have $3.13M invested in CASI Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

48% less capital invested

Capital invested by funds: $6.05M → $3.13M (-$2.92M)

83% less funds holding

Funds holding: 35 → 6 (-29)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 29

Holders
6
Holders Change
-29
Holders Change %
-82.86%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$49.4K
2
WSCM
Wellington Shields Capital Management
New York
+$5.62K

Top Sellers

1
SM
Sabby Management
Florida
-$1.95M
2
BIT
BlackRock Institutional Trust
California
-$408K
3
WJA
Williams Jones & Associates
New York
-$77K
4
California Public Employees Retirement System
California Public Employees Retirement System
California
-$76K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$70K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
– -$1K -35 Closed
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
– -$194 -11 Closed
AIG
28
American International Group
New York
– -$73 -4 Closed
1
2